We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A Corin Variant Identified in Hypertensive Patients That Alters Cytoplasmic Tail and Reduces Cell Surface Expression and Activity.
- Authors
Yue Zhang; Hui Li; Jianping Zhou; Aili Wang; Junhua Yang; Can Wang; Meng Liu; Tiantian Zhou; Li Zhu; Yonghong Zhang; Ningzheng Dong; Qingyu Wu
- Abstract
Corin is a membrane-bound protease that regulates blood pressure by activating the natriuretic peptides. CORIN variants have been associated with hypertension and heart disease in African Americans. In this study, we conducted targeted exome sequencing and identified an insertion variant, c.102_103insA, in exon 1 of the CORIN gene. Analysis of two independent cohorts showed that the variant was preferentially present in hypertensive patients (38/795 or 4.78%vs. 4/632 or 0.63% in normal individuals,p=4.14E-6). The insertion shifted the reading frame, resulting in a corin variant with a truncated cytoplasmic tail. In cell-based studies, the corin variant exhibited poor trafficking in the Golgi, reduced cell surface expression and zymogen activation, and low natriuretic peptide processing activity. Compared with normal individuals with the wild-type allele, individuals with the variant allele had lower levels of plasma corin [0.59±0.07 ng/mL (n=25) vs. 0.91 ± 0.02 ng/mL (n=215), p<0.001] and higher levels of plasma N-terminal pro-atrial natriuretic peptide (NT-pro-ANP) [2.39 ± 3.6 nmol/L (n=21) vs. 0.87 ± 0.6 nmol/L (n=48), p=0.005]. These results indicate that the variant altered corin structure and impaired the natriuretic peptide processing activity in vivo. The results highlight corin defects as an important underlying mechanism in hypertension.
- Subjects
HYPERTENSION; CELL membranes; GENE expression; NATRIURETIC peptides; HEART diseases; THERAPEUTICS; ZYMOGENS; ALLELES
- Publication
Scientific Reports, 2014, p1
- ISSN
2045-2322
- Publication type
Article
- DOI
10.1038/srep07378